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Necrotizing enterocolitis (NEC) is an acute neonatal inflammatory disease that affects
the intestine and may result in necrosis, systemic sepsis and multisystem organ failure.
NEC affects 5–10% of all infants with birth weight ≤ 1500 g or gestational age less than
30 weeks. Chorioamnionitis (CA) is the main manifestation of pathological inflammation
in the fetus and is strong associated with NEC. CA affects 20% of full-term pregnancies
and upto 60% of preterm pregnancies and, notably, is often an occult finding. Intrauterine
exposure to inflammatory stimuli may switch innate immunity cells such as macrophages
to a reactive phenotype (“priming”). Confronted with renewed inflammatory stimuli
during labour or postnatally, such sensitized cells can sustain a chronic or exaggerated
production of proinflammatory cytokines associated with NEC (two-hit hypothesis). Via
the cholinergic anti-inflammatory pathway, a neurally mediated innate anti-inflammatory
mechanism, higher levels of vagal activity are associated with lower systemic levels
of proinflammatory cytokines. This effect is mediated by the α7 subunit nicotinic
acetylcholine receptor (α7nAChR) on macrophages. The gut is the most extensive organ
innervated by the vagus nerve; it is also the primary site of innate immunity in the
newborn. Here we review the mechanisms of possible neuroimmunological brain-gut
interactions involved in the induction and control of antenatal intestinal inflammatory
response and priming.We propose a neuroimmunological framework to (1) study the long-
term effects of perinatal intestinal response to infection and (2) to uncover new targets
for preventive and therapeutic intervention.
Keywords: necrotizing enterocolitis, chorioamnionitis, preterm birth, inflammation, neuroimmunology, vagus
nerve, intestines, prevention
INTRODUCTION
In this review we summarize the emerging understanding of
the mechanisms of necrotizing enterocolitis (NEC; Table 1) of
the neonate and the clinical significance of the cholinergic anti-
inflammatory pathway (CAP) as a neuroimmunological mech-
anism to prevent NEC. We propose how this emerging under-
standing of neuroimmunological basis for the NEC etiology may
lead to new avenues of clinical research that could result in low
cost widely available treatment strategies of NEC across the world.
Overall, this review provides a comprehensive, up-to-date review
of the literature about the role of CAP in the pathogenesis of NEC
as a neuroimmunological modulation system and the emerging
therapeutic strategies.
THE BURDEN OF NEC
NEC is an acute neonatal inflammatory disease that affects the
intestine and may result in necrosis, systemic sepsis and multi-
system organ failure. The incidence varies from 0.3 to 2.4 infants
per 1000 live births, with nearly 90% of cases occurring in infants
born at less than 36 weeks’ gestation. NEC affects 5–10% of all
infants with birth weight ≤ 1500 g or gestational age less than 30
weeks, and 2–5% of all preterm neonates (Lin and Stoll, 2006).
NEC accounts for up to 8% of all admissions to the neonatal
intensive care unit. Moreover, with the increased survival of very
preterm infants with birth weights ≤ 800 g, the incidence of NEC
has increased, despite surfactant replacement therapy (Lin et al.,
2008). NEC is the leading cause of death and long-term disabil-
ity from gastrointestinal disease in preterm infants. Overall mor-
tality ranges from 10–50%, approaching 100% in infants with
the most severe form of the disease, which is characterized by
full-thickness destruction of the intestine leading to intestinal
perforation, peritonitis, bacterial invasion, sepsis and multiorgan
failure.
A NEC diagnosis in the very low birth weight infant poses
a significant burden to the individual family and the neonatal
community, as well as a serious financial burden to society as a
whole. NEC is not only one of the most serious clinical prob-
lems in neonates, but also one of the most challenging to treat.
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Table 1 | Abbreviations.
CAP Cholinergic anti-inflammatory pathway
CNS Central nervous system
ENS Enteric nervous system
LPS Lipopolysaccharide
α7nAChR α7 subunit nicotinic acetylcholine receptor
NEC Necrotizing enterocolitis
TNF-α Tumor necrosis factor alpha
Because the etiology and underlying mechanisms are unknown,
treatment is symptomatic. Minor cases and early stages are man-
aged with antibiotics and cessation of oral feeding; advanced
cases, marked by intestinal necrosis, may require intestinal
resection.
Despite several decades of research on the pathogenesis of NEC
(Hunter et al., 2008), the overall mortality rate remains high and
our overall understanding of its causes remains low. Clearly, a
more complete understanding of the causes of NEC is required
to design more effective and widely affordable preventive strate-
gies aimed at reducing the incidence of NEC as well as therapies
(Bisquera et al., 2002; Ganapathy et al., 2012).
CHORIOAMNIONITIS: PATHOLOGICAL FETAL
INFLAMMATION IS A RISK FACTOR
The events leading to NEC are complex and multifactorial,
including preterm birth, complicated early neonatal trajectory,
adverse intrauterine environment and poor perinatal transi-
tion. The most important ones are preterm birth and a his-
tory of enteral feeding (Lin and Stoll, 2006). Chorioamnioni-
tis is the main manifestation of pathological inflammation in
the fetus and affects 20% of term pregnancies and up to 60%
of preterm pregnancies and is commonly an occult finding
(Lahra and Jeffery, 2004; Gotsch et al., 2007). Chorioamnioni-
tis is histologically defined by the presence of polymorphonu-
clear infiltrates in the placenta and its membranes. Even silent,
asymptomatic inflammation may inhibit placental angiogenesis
and thus modulate the course of the pregnancy (Garnier et al.,
2008). Thus, a significant number of fetuses are exposed to var-
ious degrees of inflammation, which impacts on their intestinal
development. Chorioamnionitis associated with maternal infec-
tion has been strongly implicated in fetal intracerebral hemor-
rhage (Andrews et al., 2006, 2008; Aziz et al., 2009). However, an
increased incidence of NEC has also been reported in neonates
of mothers presenting with chorioamnionitis, in several indepen-
dent studies (Andrews et al., 2006; Aziz et al., 2009; Been et al.,
2009) as well as a recent meta-analysis (Been et al., 2013), where
clinical chorioamnionitis (OR 1.24; 95%, CI 1.02–1.52) and his-
tological chorioamnionitis with fetal involvement (CI 3.29; 95%,
OR 1.87–5.78) were significantly associated with NEC. How-
ever, the association of histological chorioamnionitis with NEC
was not statistically significant. The role of prenatal infection
in the development of NEC is most significant in very preterm
infants (24–26 weeks’ gestational age) (Aziz et al., 2009), but is
also apparent in preterm births < 32 weeks (Andrews et al., 2006;
Been et al., 2009) and in full-term births (Martinez-Tallo et al.,
1997).
TIGHT JUNCTIONS: INTESTINAL PERMEABILITY AND
INTEGRITY
After birth, the intestinal lumen is subject to external environ-
mental influences, including bacterial colonization of the gas-
trointestinal tract (Gronlund et al., 1999). Cells that cover the
intestinal surface must form a barrier to protect the “milieu
intérieur” from the external world and prevent unrestricted
exchange of materials. The intestinal epithelial barrier needs to
allow the passage of water and nutrients but prevent microbial
contamination and the invasion of interstitial tissues by foreign
antigens (Figure 1) (Turner, 2009). Tight junctions, essential to
the paracellular pathway, are the primary determinants of barrier
function. Tight junctions are situated at the apical pole of epithe-
lial cells, and comprise over 50 associated proteins. The first group
includes claudins (a family of at least 24 members) and occludin.
These proteins span the plasma membrane and are attached to a
second group of proteins including zonula occludens (ZO) -1, -2
and -3, which link them to actin and myosin in the cytoskeleton
(Turner, 2009).
The properties of tight junctions differ from one tissue to
another, as evidenced by the 1000-fold variation in electrical
resistance between different epithelia. Barrier properties are not
fixed: they can be modulated and regulated on a short- or long-
term basis. Short-term regulation is achieved by deformation of
the cytoskeleton: myosin light chain phosphorylation permits
interaction with actin and contraction of the actin filaments
in the perijunctional ring. Contraction of the actin filaments
favours the passage of macromolecules by opening the pores.
Myosin light chain kinase-1 (MLCK-1) controls the phosphory-
lation/dephosphorylation of the myosin light chains in the villus
enterocytes and surface colonocytes (Clayburgh et al., 2004).
Further downstream, during alterations of the tight junction
permeability, the transmembrane protein occludin is subject
to endocytosis (Schwarz et al., 2007; Turner, 2009). Long-term
regulation of intestinal permeability depends on the synthesis
and trafficking of claudin-2, a molecule that is overexpressed
in intestinal cells of animal models of colitis and in human
ulcerative colitis specimens (Heller et al., 2005).
It has been suggested that abnormalities in intestinal per-
meability may be key to the facilitation of intestinal inflam-
mation leading to NEC (Petrosyan et al., 2009). Intestinal bar-
rier integrity and its appropriate regulation are essential to
the prevention of antigen diffusion and bacterial contamina-
tion into the lamina propria and interstitial tissue. McElroy et al.
(2012) however, have recently suggested an alternate “bot-
tom up” hypothesis whereby NEC may be caused by injury
to the Paneth cells located in the crypts of Lieberkühn
(McElroy et al., 2012).
INTESTINAL PERMEABILITY IS INFLUENCED BY PATHOGENS
AND INFLAMMATION
Intestinal barrier dysfunction in newborns may be triggered by
exogenous agents. Such enteric pathogens trigger local inflam-
matory responses through specific receptors (e.g., toll-like recep-
tor 4 (TLR4) for lipopolysaccharide (LPS) recognition) or by
proinflammatory cytokines (e.g., tumour necrosis factor alpha
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FIGURE 1 | Structures and factors controlling paracellular permeability.
Tight junctions are luminal structures that filter the passage of ions and
macromolecules (A). The intercellular structural proteins, claudins and
occludins, are anchored to the cytoskeleton actinomyosin apical ring
through intermediary proteins (ZO-1, -2, -3, AF6). The phosphorylation of
myosin light chain causing contraction is associated with opening of tight
junctions and junction protein deformations that favour macromolecule
passage and bacterial translocation (B). The phosphorylation/
dephosphorylation of myosin light chain is controlled by myosin light chain
kinase (MLCK) and myosin phosphatase (MP). PAR-2 activation increases
MLCK activity through external and internal calcium (Ca++) mobilization and
calmodulin binding (C). (With permission from John Wiley and Sons)
(Bueno and Fioramonti, 2008).
(TNF-α) (Clayburgh et al., 2005), interferon-γ (Wang et al.,
2005), interleukin (IL) 1-β (Al-Sadi et al., 2008) and high-
mobility group box 1 (HMGB1) protein (Sappington et al.,
2002; Liu et al., 2006; Raman et al., 2006). TNF-α-induced bar-
rier loss is associated with increased transcription and transla-
tion of MLCK (Clayburgh et al., 2005). In vivo, intestinal epithe-
lial MLCK is induced by TNF-α. In the rat model of sepsis,
an intraperitoneal injection of LPS demonstrably resulted in
a rapid rise of TNF-α in the colonic mucosa followed by an
increase in myosin light chain phosphorylation and colonic per-
meability (Moriez et al., 2005). Interestingly, studies in the fetal
rat model of NEC have also shown that prenatal bacterial LPS
exposure alters the development and permeability of intesti-
nal epithelium (Giannone et al., 2006) and increases ileal injury
(Giannone et al., 2009). Similarly, in fetal sheep, preterm intra-
amniotic LPS exposure induces abnormal expression of ZO-1 in
the ileum (Wolfs et al., 2009).
ENS CONTROLS EPITHELIAL BARRIER FUNCTION
The enteric nervous system (ENS) is defined as the arrangement
of neurons and supporting cells throughout the gastrointestinal
tract, from the esophagus to the anus (Goyal and Hirano, 1996).
The ENS is organized in ganglia that contain neurons, glial cells
and interstitial cells. Each enteric ganglion contains many dif-
ferent neuron types (Furness, 2000). The ENS consists of some
one hundred million neurons, or about one-tenth of the num-
ber of neurons of the spinal cord. Glial cells in the ENS have
similar properties to those in the central nervous system (CNS)
(Gershon et al., 1993). The numbers and types of neurotransmit-
ters expressed by enteric neurons are comparable to those found
in the CNS. The ENS is capable of autonomy with elicitation of
reflexes (complete reflex circuitry in the intestinal wall comprises
intrinsic sensory neurons, interneurons and intrinsic motor neu-
rons) after total extrinsic denervation of the gut (Furness et al.,
1995). However, the ENS is under physiological influence of the
sympathetic and vagus nerves. The ENS controls intestinal motil-
ity, modulates visceral sensation and plays a role in the regula-
tion of the intestinal blood supply and the secretion of digestive
hormones (Costa and Brookes, 1994; Kunze and Furness, 1999;
Boeckxstaens, 2002). It also plays a major role in water and
electrolyte transport. As a consequence, intestinal permeability
is under neural control (Keita and Soderholm, 2010). The ENS
should thus be considered, along with the microflora, immune
system and fibroblasts, as a major player in the maintenance
of intestinal homeostasis and integrity. The ENS has the abil-
ity to fine-tune intestinal barrier function via the release of
mediators such as acetylcholine that enhance—via muscarinic
receptors—(Cameron and Perdue, 2007) and vasoactive intestinal
peptide (VIP) that constrict (Neunlist et al., 2003) intestinal per-
meability over short-term or long-term periods (Neunlist et al.,
2012). Similarly, the ENS can modulate the proliferation and
differentiation of the intestinal epithelial barrier via the secre-
tion of distinct neuromediators such as VIP (Neunlist et al.,
2012). VIP exerts antiproliferative effects, while mediators such
as acetylcholine, glucagon-like peptide 2 (GLP-2) or substance
P stimulate intestinal epithelial cell proliferation (Neunlist et al.,
2012).
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NEC: IMMATURE IMMUNE RESPONSE
Local intestinal immune response is normally tightly controlled
(Su et al., 2009).
The premature gastrointestinal tract has increased
permeability, low levels of protective mucus and secretory
immunoglobuline A, higher risk of bacterial overgrowth caused
by dysmotility due to ENS immaturity and decreased regenerative
capabilities (Neu, 2007). Uncontrolled intestinal inflammation
may result from immaturity of the innate immune system
of the developing gut (Lin and Stoll, 2006; Lin et al., 2008).
Immature regulation could lead to an exaggerated inflammatory
response, leading to greater injury and increased intestinal
barrier damage. Alternatively, immature regulation could result
in minimal immune response due to insufficient inflammatory
signalling, thus contributing to bacterial overgrowth and invasion
of interstitial tissue. The uncontrolled intestinal inflammation
observed in NEC may also depend on dysregulation of intestinal
permeability in relation to localized immune response (Turner,
2009). In most individuals and specifically in healthy full-term
newborns, a localized break in the intestinal barrier induces a
localized immune response that is finely tuned and controlled to
avoid over-inflammation and a subsequent increase of intestinal
permeability. This normal immunoregulatory response is the
result of a delicate balance between pro-inflammatory (TNF-α,
IL-1β) and anti-inflammatory (IL-10) processes. If even small
anomalies occurred in any of the components of the system
(tight junction dysregulation, immune regulatory response), the
inflammatory response would be amplified and would result
in intestinal injury. Such anomalies may occur secondary to
immaturity in preterm babies.
Furthermore immunomodulatory nutrients such as glu-
tamine, arginine, nucleotides, omega-3 polyunsaturated fatty
acids and lactoferrin are provided with enteral nutrition and pre-
vent diseases such as NEC. Difficulties with enteral feeding in the
first weeks of life predispose premature infants to sepsis and NEC
(Neu et al., 2013).
DEVELOPMENT AND MONITORING OF THE AUTONOMIC
NERVOUS SYSTEM ACTIVITY
The autonomic nervous system (ANS) plays a predominant role
in complex coordinated control of multiple vitally important
physiological subsystems in the organism and is part of the neu-
roimmunological response to pathogens via CAP (Fairchild et al.,
2011). Since ANS development and activity are reflected in the
heart rate patterns, an appropriate analysis of the fetal heart rate
variability (fHRV) may provide information regarding the indi-
vidual fetal development (Hoyer et al., 2013; Van Leeuwen et al.,
1999). fHRV is a non-invasively obtainable marker of changes
in vagal (parasympathetic) and sympathetic activity (Frank et al.,
2006). Increase in fHRV is associated with fetal growth in
general and with the increase in neural integration in particu-
lar (Van Leeuwen et al., 2013). Understanding of the dynamics
of fHRV in human and ovine fetuses during physiologic (e.g.,
sleep states) and pathophysiologic (e.g., asphyxia) conditions has
evolved over the past two decades (Karin et al., 1993; Frank et al.,
2006; Shapiro et al., 2013). Fetal heart rate (FHR) and fHRV are
regulated by a complex interplay of the parasympathetic and
sympathetic nervous systems accounting for the baseline FHR
as well as short-term and long-term variability and nonlinear
properties (Frasch et al., 2009; Gieraltowski et al., 2013). Nonlin-
ear properties of fHRV in late gestation fetuses are present and a
higher vagal tone is associated with more efficient regulation of
homeostasis (Groome et al., 1999).
CAP CONTROLS IMMUNE HOMEOSTASIS
CAP has been implicated in the regulation of the inflamma-
tory reflex in adult organisms including humans (Tracey, 2002,
2007, 2009; Cailotto et al., 2012; Olofsson et al., 2012). CAP is a
neural mechanism that influences the magnitude of the innate
immune response and maintains homeostasis. As part of CAP,
increased vagal activity inhibits the release of proinflammatory
cytokines (Figures 2,3). Vagal nerve stimulation decreases LPS-
induced systemic TNF-α release in adult rats (Borovikova et al.,
2000). Suppression of proinflammatory cytokine expression via
agonistic action on the α7 subunit nicotinic acetylcholine recep-
tor (α7nAChR) was confirmed in innate immune cells such
as macrophages (reviewed in Tracey, 2007) (Figures 2,3). Sys-
temically via CAP, this is mediated via the spleen: Adrenergic
nerve fibres in the spleen activate acetylcholine-producing T-
lymphocytes, thereby inhibiting systemic cytokine production
(Huston et al., 2007; Rosas-Ballina et al., 2011; Olofsson et al.,
2012).
Vagal nerve activity in basal conditions provides inhibitory
input that dampens innate immune response (Haensel et al.,
2008; Thayer and Fischer, 2009). The CAP influences the magni-
tude of the innate immune response and maintains homeostasis
(Tracey, 2009). Depressed vagal nerve activity is associated with
an exaggerated proinflammatory response and increased morbid-
ity and mortality in various contexts such as acute or stable coro-
nary heart disease, metabolic syndrome or impaired glucose toler-
ance and kidney failure (Haensel et al., 2008; Thayer and Fischer,
2009). The inhibitory role of CAP on innate immune function
can be thought of as analogous to the inhibitory role of the vagus
nerve on the resting heart rate (Tracey, 2009).
Under resting conditions, the inflammatory reflex helps estab-
lish the set point for the magnitude of the innate immune
response to molecules arising from infection, injury or ischemia.
Vagus nerve outputmaintains homeostasis by limiting proinflam-
matory response to the healthy, protective and non-toxic range
(Figure 4). However, when vagal activity is absent or diminished,
the set point increases; exposure to pathogens then results in an
exaggerated proinflammatory response and eventual tissue dam-
age as demonstrated in different experiments with murinemodels
(Ghia et al., 2006, 2007a,b, 2008).
Numerous factors can experimentally or clinically impair
the CAP, each resulting in an exaggerated innate immune
response. For instance, in animal models with vagotomy or
deficient in α7nAChR, the magnitude of the proinflammatory
cytokine response and the extent of tissue damage increase dur-
ing infection, haemorrhagic shock and stroke (Guarini et al.,
2003; van Westerloo et al., 2005; Ghia et al., 2008; Ottani et al.,
2009; Tracey, 2009). The observation that vagal nerve activity
influences circulating TNF-α amounts and the shock response
to endotoxemia has widespread implications. It is a previously
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FIGURE 2 | Wiring of the cholinergic anti-inflammatory pathway (CAP),
which balances cytokine production. Pathogens as well as ischemia and
other forms of injury activate cytokine production, which normally restores
health. If the cytokine response is excessive, however, then these same
mediators can cause disease. Efferent signals from the vagus nerve
inhibit cytokine production via pathways dependent on the α7 subunit
of the acetylcholine receptor (AChR) on macrophages and other cells.
Efferent vagus nerve activity also increases instantaneous heart rate
variability (HRV). A cholinergic brain network that is responsive to M1
agonists can increase the activity of CAP and also increase instantaneous
HRV. Afferent signals carried in the vagus nerve can activate an efferent
response that inhibits cytokine release, termed the inflammatory reflex
(With permission from American Society for Clinical Investigation) (Tracey,
2007).
unrecognized, direct and rapid endogenous mechanism that can
suppress the lethal effects of biological toxins. The CAP has much
shorter response times than humoral anti-inflammatory path-
ways. Electrical stimulation of the vagus nerve or administration
of α7nAChR agonists reduces the magnitude of proinflammatory
cytokine production by 50–75% but does not eliminate cytokine
activity (Borovikova et al., 2000; Tracey, 2009). Activation of CAP
has not been observed to cause immunosuppression because
maximal suppression only reduces proinflammatory cytokine lev-
els from the toxic to the healthy range (Figure 4). This concept has
been studied as a potential treatment for a range of inflammatory
diseases, including infection (reviewed in Tracey, 2009). The role
of CAP in the perinatal inflammatory response and the priming
of subsequent innate immune response require elucidation.
Adult clinical data indicate that loss of inhibition from the
CAP unleashes innate immunity, produces higher levels of proin-
flammatory mediators, and exacerbates damage to the organism
(Lindgren et al., 1993; Lanza et al., 2006; Thayer and Sternberg,
2006; Marsland et al., 2007; Sloan et al., 2007; Tateishi et al.,
2007; Haensel et al., 2008;Holman and Ng, 2008; von Kanel et al.,
2008) and exacerbation of tissue damage. Studies are needed
to explore the impact of CAP activity on chorioamnionitis
(Shapiro et al., 2013). Such studies could lead to the develop-
ment of novel prognostic markers to better identify fetuses at
risk of NEC. We hypothesize that increased CAP activity would
inhibit the activation of intestinal innate immune cells such as
macrophages and thus suppress the inflammatory response to
bacterial infection. Effectively, pathological inflammation and
intestinal permeability as a locus minoris resistentiae of incipient
NEC would be decreased or normalized.
VAGAL NERVE STIMULATION AND THE GUT INFLAMMATION
As vagal nerve stimulation stimulates CAP activity without caus-
ing immunosuppression (Borovikova et al., 2000), it has been
shown to improve intestinal inflammation in murine models
of experimental colitis (Ghia et al., 2006, 2007a,b, 2008) and
postoperative ileus (The et al., 2007; van Bree et al., 2012). The
role of intestinal macrophages seems pivotal (The et al., 2007;
Costantini et al., 2010a; Rosas-Ballina et al., 2011; van Bree et al.,
2012). In a murine model of dextran sodium sulphate-induced
colitis, Ghia et al. demonstrated an increased inflammatory
response in the colonic mucosa of the vagotomy group as com-
pared to control animals. They showed the protective effect
of vagal activity in acute colitis (Ghia et al., 2006) and in
acute relapses within a background of chronic inflammation
(Ghia et al., 2007b).
In a murine model of postoperative ileus, the anti-
inflammatory effect of intracerebroventricular injection of
semapimodwas abolished in the presence of vagotomy (The et al.,
2011). Vagal nerve stimulation also modulates intestinal perme-
ability and integrity. In amurinemodel of intestinal injury caused
by severe burns, vagal nerve stimulation performed before injury
improved intestinal barrier integrity through an efferent sig-
nalling pathway and was associated with improved tight junction
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FIGURE 3 | Cholinergic signals derived from vagus nerve stimulation
inhibit the release of TNF-α, IL-1, HMGB1, and other cytokines by
transducing a cellular signal that inhibits the nuclear activity of NF-κB.
TNFR stands for TNF receptor (Wang et al., 2004; Tracey, 2007). The
cytokine producing cell can be a macrophage, among others. The nAChR
family are ligand-gated ion channels that mediate diverse physiological
functions and were originally identified in the nervous system. They consist
of different subtypes formed by the specific assembly of five polypeptide
subunits including α1-10, β1-4, γ , δ, and . The subunits fall into two
groups: neuronal nicotinic receptors (consisting of α2–10 and β2–4) and
muscle nicotinic receptors (consisting of α1, β1, γ , δ, and ). Functional
neuronal nAChR subtypes are either homomeric (consisting of 5 identical
α-subunits, as in α7- or α9 nAChR) or heteromeric (consisting of
combinations of the α- and β-subunits, such as α3β2nAChR) (Yeboah et al.,
2008). Remarkably, it is specifically the α7nAChR that is required for CAP’s
effects on peripheral innate immune cells (Figures 2,3) (With permission
from American Society for Clinical Investigation) (Tracey, 2007).
protein expression (Costantini et al., 2010b). In the same model,
stimulating the vagus nerve at the time of injury promoted enteric
glial cell activation. Either method could prevent intestinal barrier
injury (Costantini et al., 2010a). Activation of enteric glial cells
has been reported in a rat model of burn-induced stress and gut
injury (Costantini et al., 2010a).
The optimal choice of vagal nerve stimulation parame-
ters in order to activate the CAP for therapeutic purposes
remains challenging. Although the literature provides a spectrum
of possibilities, further studies are needed. Huston et al., 2007
demonstrated improved survival in murine polymicrobial sep-
sis with transcutaneous vagal nerve stimulation (Huston et al.,
2007), suggesting that this mode might be an effective ther-
apy for sepsis generally and NEC specifically. Pharmacologi-
cally, cholinergic neuronal circuitry can be stimulated periph-
erally using α7nAChR agonists to act on macrophages; or
centrally using intracerebroventricular injections of semapi-
mod (The et al., 2011), muscarinic receptor agonist McN-A-343
(Pavlov et al., 2006), or an acetylcholinesterase inhibitor (galan-
tamine) (Pavlov et al., 2009). Importantly, enteral feeding of lipid-
rich nutrition may also be used to activate the CAP pathway
(Luyer et al., 2005).
SIGNIFICANCE AND NOVELTY
Intrauterine infection leads to macrophage activation in LPS-
induced chorioamnionitis in fetal sheep and in a rat model of
FIGURE 4 | The set point function of the immune response is defined
by the magnitude of innate immune responses relative to the infection
or injury stimulus. Increasing the set point or shifting the curve to the left
increases the chance that tissue damage will occur from the response to
infection or injury. Decreasing the set point or shifting the curve to the right
reduces the probability that tissue damage will occur. CAP is the neural
circuit that provides acute compensatory input to adjust the magnitude of
the immune response relative to the set point (With permission from
Nature Publishing Group) (Tracey, 2009).
postnatal sepsis. Intrauterine infection may prime innate immune
cells for subsequent exacerbated response and increase intestinal
permeability. However, the effects of CAP on this process have
not been elucidated. The existence of CAP in adult mammals,
including humans, is by now well established. CAP may play an
important role in fetal and perinatal development by serving as a
neuroimmunological network for “internal surveillance” linking
the CNS and the vagus nerve to modulate systemic and intestinal
inflammation. The presence of such a brain-gut network and its
significance for perinatal health have not yet been fully studied.
Further research on the physiology and pathophysiology of fetal
and perinatal neuroimmunological interactions may open new
avenues for diagnosis of fetuses at risk of intestinal injury, such
that appropriate preventive or therapeutic interventions may be
taken. Specifically, fetal CAP activation is likely to suppress the
adverse effects of macrophage activation thus decreasing ante-
natal and perinatal intestinal injury. New pharmacologic tar-
gets or validated non-invasive methods of vagus nerve stimu-
lation for manipulating the inflammatory response in compro-
mised fetuses may emerge to improve perinatal and postnatal
outcome.
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